loadpatents
name:-0.049086093902588
name:-0.016139984130859
name:-0.0004270076751709
Lerner; E. Itzhak Patent Filings

Lerner; E. Itzhak

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lerner; E. Itzhak.The latest application filed is for "formulations of 6-mercaptopurine".

Company Profile
0.17.44
  • Lerner; E. Itzhak - Petach Tikva IL
  • Lerner, E. Itzhak - Petach Tiqva IL
  • Lerner; E. Itzhak - Petah Tikva IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Formulations Of 6-mercaptopurine
App 20160296473 - Lerner; E. Itzhak ;   et al.
2016-10-13
Formulations of 6-mercaptopurine
Grant 9,375,403 - Lerner , et al. June 28, 2
2016-06-28
Formulations of 6-mercaptopurine
Grant 9,180,097 - Lerner , et al. November 10, 2
2015-11-10
Formulations Of 6-mercaptopurine
App 20150290133 - Lerner; E. Itzhak ;   et al.
2015-10-15
Risperidone microparticles formed by sublimation
Grant 9,107,832 - Lerner , et al. August 18, 2
2015-08-18
Formulations Of 6-mercaptopurine
App 20140161888 - Lerner; E. Itzhak ;   et al.
2014-06-12
Drug Microparticles
App 20140134256 - LERNER; E. Itzhak ;   et al.
2014-05-15
Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them
Grant 8,663,703 - Lerner , et al. March 4, 2
2014-03-04
Formulations of 6-mercaptopurine
Grant 8,653,060 - Lerner , et al. February 18, 2
2014-02-18
Formulations Of 6-mercaptopurine
App 20120207841 - Lerner; E. Itzhak ;   et al.
2012-08-16
Formulations of 6-mercaptopurine
Grant 8,188,067 - Lerner , et al. May 29, 2
2012-05-29
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
App 20100278912 - Fleshner-Barak; Moshe ;   et al.
2010-11-04
Drug Microparticles
App 20100092568 - Lerner; E. Itzhak ;   et al.
2010-04-15
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
Grant 7,674,480 - Fleshner-Barak , et al. March 9, 2
2010-03-09
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
Grant 7,611,722 - Lerner , et al. November 3, 2
2009-11-03
Therapy using a combination of raloxifene and alendronate
Grant 7,579,333 - Lerner , et al. August 25, 2
2009-08-25
Delayed release formulations of 6-mercaptopurine
App 20090042914 - Lerner; E. Itzhak ;   et al.
2009-02-12
Drug microparticles
App 20080057129 - Lerner; E. Itzhak ;   et al.
2008-03-06
Levodopa compositions
App 20070178149 - Flashner-Barak; Moshe ;   et al.
2007-08-02
Pharmaceutical formulations of fenofibrate having improved bioavailability
App 20070148233 - Lerner; E. Itzhak ;   et al.
2007-06-28
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
Grant 7,195,778 - Fleshner-Barak , et al. March 27, 2
2007-03-27
Formulations of fenofibrate containing menthol
App 20070015833 - Flashner-Barak; Moshe ;   et al.
2007-01-18
Formulations of fenofibrate containing PEG/Poloxamer
App 20070015834 - Flashner-Barak; Moshe ;   et al.
2007-01-18
Controlled release dosage forms
App 20060233880 - Lerner; E. Itzhak ;   et al.
2006-10-19
Controlled released dosage forms
App 20060233879 - Lerner; E. Itzhak ;   et al.
2006-10-19
Formulations of fenofibrate
App 20060222707 - Lerner; E. Itzhak ;   et al.
2006-10-05
Formulations of Fenofibrate
App 20060222706 - Flashner-Barak; Moshe ;   et al.
2006-10-05
Dosage forms with an enterically coated core tablet
App 20060153918 - Lerner; E. Itzhak ;   et al.
2006-07-13
Drug microparticles
App 20060141052 - Lerner; E. Itzhak ;   et al.
2006-06-29
Drug microparticles
App 20060141051 - Lerner; E. Itzhak ;   et al.
2006-06-29
Cyclosporin formulations
App 20060141028 - Flashner-Barak; Moshe ;   et al.
2006-06-29
Pharmaceutical dosage forms including rasagiline
App 20060018957 - Lerner; E. Itzhak ;   et al.
2006-01-26
Formulations of 6-mercaptopurine
App 20060009473 - Lerner; E. Itzhak ;   et al.
2006-01-12
Delayed release formulations of 6-mercaptopurine
App 20060008520 - Lerner; E. Itzhak ;   et al.
2006-01-12
Therapy using a combination of raloxifene and alendronate
App 20050282784 - Lerner, E. Itzhak ;   et al.
2005-12-22
Simvastatin formulations and methods of making same
App 20050192340 - Flashner-Barak, Moshe ;   et al.
2005-09-01
Nanoparticles for drug delivery
App 20050170004 - Rosenberger, Vered ;   et al.
2005-08-04
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
App 20050112202 - Lerner, E. Itzhak ;   et al.
2005-05-26
Composition and dosage form for sustained effect of levodopa
App 20050113452 - Flashner-Barak, Moshe ;   et al.
2005-05-26
Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
Grant 6,881,420 - Flashner-Barak , et al. April 19, 2
2005-04-19
Compositions and dosage forms for gasteric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferation
App 20050048086 - Flashner-Barak, Moshe ;   et al.
2005-03-03
Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
App 20050026871 - Flashner-Barak, Moshe ;   et al.
2005-02-03
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
App 20040234608 - Fleshner-Barak, Moshe ;   et al.
2004-11-25
Menthol solutions of drugs
App 20040198646 - Flashner-Barak, Moshe ;   et al.
2004-10-07
Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or buccally
App 20040122065 - Lerner, E. Itzhak ;   et al.
2004-06-24
Microparticle pharmaceutical compositions for intratumoral delivery
App 20040092577 - Lerner, E. Itzhak ;   et al.
2004-05-13
Controlled release dosage forms
App 20040052843 - Lerner, E. Itzhak ;   et al.
2004-03-18
Drug microparticles
App 20030224059 - Lerner, E. Itzhak ;   et al.
2003-12-04
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
App 20030206954 - Lerner, E. Itzhak ;   et al.
2003-11-06
Delayed total release two pulse gastrointestinal drug delivery system
Grant 6,632,451 - Penhasi , et al. October 14, 2
2003-10-14
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
App 20030143257 - Fleshner-Barak, Moshe ;   et al.
2003-07-31
Immediate release gastrointestinal drug delivery system
Grant 6,531,152 - Lerner , et al. March 11, 2
2003-03-11
Compositions and dosage forms for gastric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferation
App 20020147208 - Fleshner-Barak, Moshe ;   et al.
2002-10-10
Delayed Total Release Two Pulse Gastrointestinal Drug Delivery System
App 20020110593 - PENHASI, ADEL ;   et al.
2002-08-15
Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
App 20010024657 - Lerner, E. Itzhak ;   et al.
2001-09-27
Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
Grant 6,197,331 - Lerner , et al. March 6, 2
2001-03-06
Gastrointestinal drug delivery system
Grant 5,840,332 - Lerner , et al. November 24, 1
1998-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed